Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction

Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge.

Date Reviewed: November 19, 2017
Support
    Group/Practice Individual Clinician

Measure Info

MIPS 008 NQF 0083 CMS 008 NQF Endorsed
Measure Type
Process
Measure Steward
Physician Consortium for Performance Improvement
Clinical Topic Area
Heart Failure
Care Setting
Home Care
Inpatient
Outpatient
Post-Acute Care
Data Source
Electronic Health Records
Registry

ACP supports QPP measure 008: “Heart Failure: Beta-blocker therapy for Left Ventricular Systolic Dysfunction” because the balance of evidence shows that long-term treatment with beta-blockers can lessen the symptoms of heart failure, improve the clinical status of patients, and enhance the patient’s overall sense of well- being. Furthermore, the measure aligns with current guidelines and represents high-value care for patients with chronic heart failure.